CAMBRIDGE, Mass.--(BUSINESS WIRE)--Phase 2 Results Published in Eye and Contact Lens Demonstrate Statistically Significant and Clinically Meaningful Improvements with EBI-005 and Support Planned Phase 3 Clinical Study Design
Uncategorized